Jpmorgan Chase & Co »

Biomarin Pharmaceutical shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-06-30 $12M 12M 0.96
2024-03-31 $7.1M 7.2M 0.99
2023-12-31 $5.6M 5.4M 1.03
2023-09-30 $386k 389k 0.99

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf (SPY)
Meta Platforms Common (META)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Broadcom Common (AVGO)
Alphabet Common (GOOGL)
Vanguard Total Intl Bond Etf Fund (BNDX)
Vanguard S&p 500 Etf idx (VOO)
Ishares Core S&p 500 Etf Fund (IVV)

View all positions for Jpmorgan Chase & Co

Top funds holding Biomarin Pharmaceutical

MacKay Shields
Wellesley Investment Advisors
Lazard Asset Management
Victory Capital Management
iA Global Asset Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
State Street Corporation
Jpmorgan Chase & Co
Schroder Investment Management Group
Shenkman Capital Management
Morgan Stanley
Sonora Investment Management Group
Leucadia National Corporation
Bank of America Corporation
Invesco

View all funds holding Biomarin Pharmaceutical